Predictors of unknown cancer in patients with ischemic stroke - Quintas, S.; Rogado, J.; Gullón, P.; Pacheco-Barcia, V.; Dotor García-Soto, J.; Reig-Roselló, G.; Mondéjar, R.; Colomer, R.; Vivancos, J. (Journal Of Neuro-Oncology, 2018)

Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy - Carmona-Bayonas, A.; Calderón, C.; Hernández, R.; Fernández Montes, A.; Castelo, B.; Ciria-Suarez, L.; Antoñanzas, M.; Rogado, J.; Pacheco-Barcia, V.; Asensio Martínez, E.; Ivars, A.; Ayala de la Peña, F.; et al. (npj Breast Cancer, 2021)

Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies - Rogado, J.; Romero-Laorden, N.; Sanchez-Torres, J.M.; Ramos-Levi, A.M.; Pacheco-Barcia, V.; Ballesteros, A.I.; Arranz, R.; Lorenzo, A.; Gullon, P.; Garrido, A.; Serra López-Matencio, J.M.; Donnay, O.; et al. (Oncoimmunology, 2020)

Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients - Rogado, J.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Leví, A.; Arranz, R.; Lorenzo, A.; Gullón, P.; Donnay, O.; Adrados, M.; Costas, P.; et al. (European Journal Of Cancer, 2019)

Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM) - Jiménez-Labaig, P.; Pacheco-Barcia, V.; Cebrià, A.; Gálvez, F.; Obispo, B.; Páez, D.; Quílez, A.; Quintanar, T.; Ramchandani, A.; Remon, J.; Rogado, J.; Sánchez, D.A.; et al. (ESMO open, 2021)

Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents - Pacheco-Barcia, V.; Mondéjar, R.; Martínez-Sáez, O.; Longo, F.; Moreno, J.A.; Rogado, J.; Donnay, O.; Santander, C.; Carrato, A.; Colomer, R. (Clinical Colorectal Cancer, 2019)

The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair - Pacheco?barcia, V.; Muñoz, A.; Castro, E.; Ballesteros, A.I.; Marquina, G.; González?díaz, I.; Colomer, R.; Romero?laorden, N. (Cancers, 2022)

Stoic attitude in patients with cancer from the NEOcoping study: Cross-sectional study - Gomez, D.; Carmona-Bayonas, A.; Hernandez, R.; Higuera, O.; Rogado, J.; Pacheco-Barcia, V.; Valero, M.; Gil-Raga, M.; Muñoz, M.M.; Carrión-Galindo, R.; Jimenez-Fonseca, P.; Calderon, C. (PLoS ONE, 2022)

Role of sex on psychological distress, quality of life, and coping of patients with advanced colorectal and non-colorectal cancer - Pacheco-Barcia, V.; Gomez, D.; Obispo, B.; Gongora, L.M.; Gil, R.H.S.; Cruz-Castellanos, P.; Gil-Raga, M.; Villalba, V.; Ghanem, I.; Jimenez-Fonseca, P.; Calderon, C. (World Journal of Gastrointestinal Oncology, 2022)

Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section - Martinez, D.A.S.; Quilez-Cutillas, A.; Jimenez-Labaig, P.; Sesma, A.; Tarazona, N.; Pacheco-Barcia, V.; Obispo, B.; Paez, D.; Quintanar, T.; Sanchez-Canovas, M.; Montes, A.F.; Felip, E.; et al. (Clinical and Translational Oncology, 2023)

Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality - Mihic-Gongora, L.; Jiménez-Fonseca, P.; Hernandez, R.; Gil-Raga, M.; Pacheco-Barcia, V.; Manzano-Fernández, A.; Hernando-Polo, S.; Antoñanzas-Basa, M.; Corral, M.J.; Valero-Arbizu, M.; Calderon, C. (BMC Palliative Care, 2022)

Excess weight and anti-PD-1 immune checkpoint inhibitor?s outcomes in non-small cell lung cancer - Rogado, J.; Pozo, F.; Troulé, K.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Mondejar, R.; Donnay, O.; Ballesteros, A.; Pacheco-Barcia, V.; Aspa, J.; Al-Shahrour, F.; Alfranca, A.; et al. (Clinical & Translational Oncology, 2022)

Progress and oncological outcome of neoadjuvant therapy in breast cancer patients during a 10-year period - Ballesteros, A.I.; López, M.P.; Mondejar, R.; Pacheco-Barcia, V.; Donnay, O.; Hernández, B.; Romero-Laorden, N.; Doblado, B.; Álvarez López, R.M.; Pérez-Fernández, E.; Colomer, R. (Revista De Senologia Y Patologia Mamaria, 2022)

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC - Rogado, J.; Pozo, F.; Troule, K.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Mondejar, R.; Donnay, O.; Ballesteros, A.; Pacheco-Barcia, V.; Aspa, J.; Al-Shahrour, F.; Alfranca, A.; et al. (Cancers, 2022)

Correction to: Optimism and social support as contributing factors to spirituality in Cancer patients (Supportive Care in Cancer, (2021), 29, 6, (3367-3373), 10.1007/s00520-020-05954-4) - Ciria-Suarez, L.; Calderon, C.; Montes, A.F.; Antoñanzas, M.; Hernández, R.; Rogado, J.; Pacheco-Barcia, V.; Asensio-Martínez, E.; Palacín-Lois, M.; Jimenez-Fonseca, P. (Supportive Care in Cancer, 2021)

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer - Pacheco-Barcia, V.; Mondéjar Solís, R.; France, T.; Asselah, J.; Donnay, O.; Zogopoulos, G.; Bouganim, N.; Guo, K.; Rogado, J.; Martin, E.; Alcindor, T.; Colomer, R. (Pancreatology, 2020)

A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer - Pacheco-Barcia, V.; Mondéjar Solís, R.; France, T.; Asselah, J.; Donnay, O.; Zogopoulos, G.; Bouganim, N.; Guo, K.; Rogado, J.; Martin, E.; Alcindor, T.; Colomer, R. (Pancreas, 2019)

Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome - Gómez-León, N.; Pacheco-Barcia, V.; Ballesteros, A.I.; Fraga, J.; Colomer, R.; Friera, A. (Melanoma Research, 2018)

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy - Jimenez-Fonseca, P.; Foy, V.; Raby, S.; Carmona-Bayonas, A.; Macía-Rivas, L.; Arrazubi, V.; Cacho Lavin, D.; Hernandez San Gil, R.; Custodio, A.; Cano, J.M.; Fernández Montes, A.; Mirallas, O.; et al. (Therapeutic Advances in Medical Oncology, 2023)

Eritrodisestesia palmoplantar tras tratamiento perioperatorio con quimioterapia - P Granda Lobato; P. Sánchez López; Vilma Emilia Pacheco Barcia; P. Prats Oliván; Mª H. Gonzalo Salado; G. Barrena Castello (Sanidad militar: revista de sanidad de las Fuerzas Armadas de España, 2022)

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group - Sánchez Cánovas, M.; Fernández Garay, D.; Gómez Martínez, F.; Brozos Vázquez, E.; Lobo de Mena, M.; García Adrián, S.; Pacheco-Barcía, V.; Cacho Lavin, D.; Martínez de Castro, E.; Martín Fernández de Soignie, A.M.; Martínez, E.; Rúperez Blanco, A.B.; et al. (Clinical and Translational Oncology, 2023)

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma - Lara-Morga, C.; Palka-Kotlowska, M.; Custodio-Cabello, S.; Pacheco-Barcia, V.; Cabezón-Gutiérrez, L. (Exploration of Targeted Anti-tumor Therapy, 2023)

Psychological factors and prognostic communication preferences in advanced cancer: multicentre study - Ramchandani, A.; Mihic-Góngora, L.; Hernández, R.; Zafra-Poves, M.; Muñoz, M.M.; Ferreira, E.; Cruz-Castellanos, P.; Fernández-Montes, A.; Pacheco-Barcia, V.; Jiménez-Fonseca, P.; Calderon, C. (BMJ Supportive and Palliative Care, 2023)